Caplin Point Laboratories Ltd. (CAPLIPOINT) Share Price Falls 5.68%: Price Action, Sector and Peer Analysis

Caplin Point Laboratories Ltd. fell to Rs 2475, down 5.68% today, with market capitalisation at Rs 19,930.27 crore as the mid-cap stock turned a notable decliner.

Caplin Point Laboratories Ltd. Share Price fell to Rs 2475 on 12 August 2026, down 5.68% from the previous close of Rs 2624.15, taking the company’s market capitalisation to Rs 19,930.27 crore. The move puts the stock firmly in focus in today’s Stock Market Today conversation because it was sharp enough to qualify under the workflow’s price fall threshold event for its market-cap bucket.

Caplin Point Laboratories Ltd. Share Price Today reflects a same-session decline of Rs 149.15, with the stock opening at Rs 2638.8, touching an intraday high of Rs 2661.85 and falling to a low of Rs 2461.55. The supplied data confirms the price event and shows that selling pressure strengthened as the session progressed. At the same time, the dataset does not establish a company-specific catalyst behind the fall, so today’s Caplin Point Laboratories Ltd. Stock News remains centred on verified market action rather than an attributed trigger.

Why is the stock falling and trending? The verified answer is straightforward: the share price decline was large on a single day, the trading range widened, and the stock entered the Top Losers Today screen through the PRICE_FALL_THRESHOLD event. Important financial context includes its Rs 19,930.27 crore Market Cap and its position inside the Healthcare sector benchmark set of 196 companies. What should investors monitor next? Price action around today’s low, whether turnover and total volume stay elevated, and how the stock’s scale compares with peers and the wider Healthcare benchmark. Univest notes that this combination makes Caplin Point Laboratories Ltd. Share Price a relevant stock analysis topic today.

Caplin Point Laboratories Ltd. (CAPLIPOINT) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,475
Previous Close	Rs 2,624.15
Today's Change	Rs -149.15 (-5.68%)
Day Open	Rs 2,638.8
Day High	Rs 2,661.85
Day Low	Rs 2,461.55
Current Volume (BSE)	19,156
BSE Traded Volume	19,156
NSE Traded Volume	4,14,008
Combined NSE + BSE Volume	4,33,164
Turnover	Rs 4.74 crore
Market Capitalisation	Rs 19,930.27 crore
Market Cap Category	Mid Cap

Caplin Point Laboratories Ltd. (CAPLIPOINT) traded at Rs 2,475. versus the previous close of Rs 2,624.15, a fall of 5.68%. The stock opened at Rs 2,638.8, reached Rs 2,661.85, touched Rs 2,461.55. Reported volume was 19,156.

Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 19,930.27 crore

Caplin Point Laboratories Ltd. Fundamental Analysis, based strictly on the supplied data, offers useful scale and valuation context even without a full set of company financial ratios. The key verified anchor is market capitalisation: at Rs 19,930.27 crore, the company sits well above many Healthcare benchmark constituents by size, which shapes how investors interpret today’s share price decline.

Market capitalisation indicates company size rather than quality, but size still matters in Stock Analysis because it influences liquidity, institutional relevance and benchmark visibility. In this case, Caplin Point Laboratories Ltd. Market Cap of Rs 19,930.27 crore stands far above the Healthcare sector benchmark median market cap of Rs 142.81 crore and the average of Rs 461.64 crore across 196 companies. That gap means the stock occupies a substantially larger position than the typical company in the same sector dataset.

From a fundamental analysis standpoint, today’s event therefore carries two layers. First, the absolute fall of Rs 149.15 and percentage decline of 5.68% are meaningful on their own. Second, the move happened in a company with a market size that is multiple times larger than the benchmark averages supplied for the sector. That makes Caplin Point Laboratories Ltd. Stock Performance noteworthy within the Healthcare space, especially for investors comparing scale across sector names.

The supplied company-level valuation fields such as P/E Ratio, P/B Ratio, ROE, ROCE, EPS, Book Value, Dividend Yield and leverage measures are not part of this dataset, so the most defensible fundamental context today comes from size, listed peer positioning and sector benchmarks. As Univest reads the numbers, Caplin Point Laboratories Ltd. Share Price is attracting attention not because the data proves a balance-sheet or earnings shock, but because a mid-cap Healthcare name with Rs 19,930.27 crore in market value registered a sharp same-day decline. That leads naturally into ownership structure, sector benchmarks and peer comparison, where relative positioning becomes more visible.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	25.58x
Benchmark Average P/E	81.68x
Benchmark P/E Range	3.31x to 3,374.81x
Benchmark Median P/B	1.9x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 19,930.27 crore
Benchmark Median Market Cap	Rs 142.81 crore

Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

The Healthcare sector snapshot provides the clearest benchmark for understanding where this stock sits in a wider industry frame. Today’s Caplin Point Laboratories Ltd. Share Price fall happened inside a benchmark universe of 196 same-sector companies, allowing investors to compare company scale and available valuation ranges against a broader listed set.

The supplied sector benchmark is Healthcare, with 196 companies in scope for market-cap comparison and broadly similar counts for valuation and return metrics. Within that universe, the median P/E stands at 25.58 and the average P/E at 81.68, across 156 companies, with the range stretching from 3.31 to 3374.81. For price-to-book, the median is 1.9 and the average is 2.6 across 195 companies, while the P/B range runs from -16.74 to 16.32. On profitability, median ROE is 11.07 and average ROE is 15.45 across 195 companies; median ROCE is 13.35 and average ROCE is 17.8, also across 195 companies.

The most striking comparison for Caplin Point Laboratories Ltd. Share Price is company size. Its market capitalisation of Rs 19,930.27 crore is dramatically above the Healthcare benchmark median of Rs 142.81 crore, the average of Rs 461.64 crore, and even the supplied benchmark maximum of Rs 2,949.87 crore. This indicates that the stock sits at a much larger scale than the benchmark constituents listed in the snapshot, which is relevant when assessing how unusual today’s move is in a sector context.

The benchmark also shows how dispersed Healthcare valuations and returns can be. Some companies in the same broad sector trade on low P/E multiples, while others command very high valuations; the same variability applies to P/B and profitability. That matters because broad sector labels alone do not explain any one day’s Market News. For Univest readers tracking Caplin Point Laboratories Ltd. Latest News and Caplin Point Laboratories Ltd. Company News, the verified takeaway is that today’s price fall occurred in a large-capitalisation outlier relative to the supplied Healthcare benchmark set, not in a typical small benchmark constituent.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,949.87	31.07	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,775.9	71.31	11.28	18.65	22.17
Hikal Ltd.	HIKAL	2,761.32	0	2.26	15.22	16.15
Sai Parenteral's Ltd.	SAIPARENT	2,594.65	179.52	3.32	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,561.88	33.61	6.93	-2.6	16.92

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 19,930.27 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The peer snapshot shows that relative company size is the biggest differentiator in this dataset. While peers provide valuation and profitability markers, Caplin Point Laboratories Ltd. Share Price is attached to a market value far above every listed peer supplied, which changes how investors frame today’s stock performance.

Among the supplied peers, Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,949.87 crore, Beta Drugs Ltd. Rs 2,775.9 crore, Hikal Ltd. Rs 2,761.32 crore, Sai Parenteral's Ltd. Rs 2,594.65 crore and Dr Agarwals Eye Hospital Ltd. Rs 2,561.88 crore. Caplin Point Laboratories Ltd. Market Cap at Rs 19,930.27 crore is substantially larger than all of them. That does not by itself indicate stronger or weaker fundamentals, but it does show that the market assigns this company a very different scale from the listed comparison set provided.

On valuation and return metrics, the peers show a wide spread. Dishman Carbogen trades at 31.07 times earnings with ROE of -2.89% and ROCE of -0.26%. Beta Drugs is at a P/E of 71.31 with ROE of 18.65% and ROCE of 22.17%. Sai Parenteral's stands at 179.52 times earnings with ROE of 13.9% and ROCE of 12.97%. Hester Biosciences trades at 15.51 times earnings with ROE of 16.17% and ROCE of 14.12%, while NGL Fine-Chem is at 44.41 times earnings with ROE of 27.9% and ROCE of 33.91%.

Price-to-book ratios also vary materially, from 0.45 for Dishman Carbogen to 11.28 for Beta Drugs, 6.93 for Dr Agarwals Eye Hospital, 6.49 for NGL Fine-Chem and 1.65 for Ind-Swift Laboratories. Because the dataset does not include company-level P/E, P/B, ROE or ROCE for Caplin Point Laboratories Ltd., the most reliable peer insight today is comparative scale and the fact that Healthcare and pharmaceutical-type peers carry very different profitability and valuation profiles. For Caplin Point Laboratories Ltd. Stock Analysis, that means the share price fall should be read alongside peer dispersion rather than through a single sector multiple.

Why Investors Are Watching Caplin Point Laboratories Ltd.

Investors are watching this stock because the move was both sharp and visible. Caplin Point Laboratories Ltd. Share Price declined 5.68% in a single session, turned up in a price-fall event screen, and did so despite opening above the previous close. That combination keeps the stock relevant in Share Market Today discussions.

• Verified price action: the stock fell from a previous close of Rs 2624.15 to Rs 2475, after opening at Rs 2638.8 and touching a low of Rs 2461.55.
• Trading activity: total volume reached 4,33,164 shares, with 4,14,008 on NSE and 19,156 on BSE, while turnover stood at Rs 4.74 crore.
• Market-cap context: it is categorised as a Mid Cap stock with a market capitalisation of Rs 19,930.27 crore.
• Sector positioning: its market value is much larger than the supplied Healthcare benchmark median and average.
• Peer framing: the stock’s market cap is well above all listed peers in the supplied comparison basket.

What should investors monitor next? The next checkpoints are whether Caplin Point Laboratories Ltd. Share Price stabilises near today’s low band or continues to show weak momentum in subsequent sessions, whether Trading Volume remains elevated, and whether the stock continues to feature prominently in market movers lists on Univest and other Indian Stock Market screens.

About Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd. is the subject of today’s Healthcare sector stock update and is tracked in the market as CAPLIPOINT. The supplied dataset places the company within the Healthcare sector and frames it against a same-sector benchmark of 196 listed companies. That benchmark includes several companies from Pharmaceuticals & Drugs as well as Hospital & Healthcare Services, showing the breadth of the sector context around this stock.

For investors following Caplin Point Laboratories Ltd. Stock News, the most concrete company context available in this dataset is its listed market presence. At Rs 19,930.27 crore in market capitalisation, the company stands out sharply versus the sector benchmark’s median and average market values and also versus the peer basket supplied alongside this article. In other words, this is not a marginal listed name inside the Healthcare universe; it is a substantially larger company by market value than the comparison set shown here.

That is why today’s Caplin Point Laboratories Ltd. Share Price Fall is drawing attention. A 5.68% decline in a company of this size becomes a meaningful part of Market Update coverage even when the data does not identify a company-specific trigger. Univest therefore focuses on verified exchange data, peer context and benchmark comparisons to help readers understand why the stock is trending in today’s Stocks in News and Stocks Under Pressure discussions.

Track Caplin Point Laboratories Ltd. Share Price on Univest

Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors using Univest can track Caplin Point Laboratories Ltd. Share Price through live market moves, end-of-day price updates and broader stock analysis modules. Univest also helps users follow Caplin Point Laboratories Ltd. Share Price Today alongside market capitalisation, exchange-wise activity, 52-week levels when available, technical indicators when supplied, fundamental ratios, shareholding pattern and sector context.

For readers checking Caplin Point Laboratories Ltd. Share Price Update, Caplin Point Laboratories Ltd. NSE activity, Caplin Point Laboratories Ltd. BSE activity and Healthcare sector comparisons, Univest brings the numbers into a single research-style view. The goal is not to issue a recommendation, but to make it easier to monitor price action, benchmark positioning, peer comparisons and ongoing stock performance with verified market data.

Frequently Asked Questions

Why is Caplin Point Laboratories Ltd. Share Price falling today?

Ans. Caplin Point Laboratories Ltd. Share Price fell because the stock declined 5.68% in the current session, dropping from Rs 2624.15 to Rs 2475. The supplied data confirms the price fall and trading activity, but does not identify a company-specific catalyst.

What is Caplin Point Laboratories Ltd. Share Price Today?

Ans. Caplin Point Laboratories Ltd. Share Price Today is Rs 2475. That is Rs 149.15 below the previous close of Rs 2624.15, translating into a 5.68% single-day decline and placing the stock among notable market decliners.

How much did Caplin Point Laboratories Ltd. stock fall today?

Ans. The stock fell by Rs 149.15 today, which equals a 5.68% decline from the previous close. The move qualifies as a significant same-day price fall in the supplied event framework for this Mid Cap company.

What were the day high, day low and opening price for Caplin Point Laboratories Ltd.?

Ans. The stock opened at Rs 2638.8, touched an intraday high of Rs 2661.85 and later fell to a low of Rs 2461.55. This wide session range highlights the volatility seen during today’s price action.

What is the market capitalisation of Caplin Point Laboratories Ltd.?

Ans. Caplin Point Laboratories Ltd. has a market capitalisation of Rs 19,930.27 crore. That makes it much larger than the Healthcare benchmark median of Rs 142.81 crore and average of Rs 461.64 crore in the supplied sector dataset.

How much volume was traded in Caplin Point Laboratories Ltd. today?

Ans. Total traded volume was 4,33,164 shares today. Of this, NSE accounted for 4,14,008 shares and BSE for 19,156 shares, while the supplied turnover figure stood at Rs 4.74 crore for the session.

Which sector does Caplin Point Laboratories Ltd. belong to?

Ans. The company is placed in the Healthcare sector in the supplied dataset. The benchmark used for comparison includes 196 same-sector companies, allowing investors to compare market size, valuation ranges and profitability benchmarks across Healthcare names.

How does Caplin Point Laboratories Ltd. compare with its peers by market cap?

Ans. By market value, Caplin Point Laboratories Ltd. stands well above the supplied peers. Its Rs 19,930.27 crore market cap exceeds Dishman Carbogen at Rs 2,949.87 crore and Beta Drugs at Rs 2,775.9 crore by a large margin.

Is Caplin Point Laboratories Ltd. among today’s top losers?

Ans. The supplied screener code is TOP_LOSERS, and the stock also triggered the PRICE_FALL_THRESHOLD event. Together, those fields indicate that Caplin Point Laboratories Ltd. featured among the session’s prominent decliners in today’s market action.

What should investors monitor after today’s Caplin Point Laboratories Ltd. Share Price fall?

Ans. Investors can monitor whether the stock holds near today’s low of Rs 2461.55 or stabilises, whether total volume remains elevated after 4,33,164 shares traded, and how the stock continues to rank within Healthcare market movers.